[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Novo-Nordisk (NVO)

Novo Nordisk is facing legal battles over its semaglutide drug patents, with Delhi High Court hearing pleas against Sun Pharma and a pending dispute with Dr. Reddy's Laboratories. Meanwhile, analysts are debating its valuation against competitors like Eli Lilly, with some seeing undervaluation and others highlighting market share concerns.

### About Novo-Nordisk
Novo Nordisk is a pharmaceutical company specializing in diabetes and obesity treatments.  
Novo-Nordisk uses the ticker $NVO for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Novo-Nordisk (NVO) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Novo-Nordisk (NVO) trading volume is up XXXXX% from the previous month.
- Novo-Nordisk (NVO) social dominance is up XXXXXX% from the previous week.
- Novo-Nordisk (NVO) Galaxy Score™ is up XXXXX% from the previous week.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/close.tsv)  
The stock price is showing signs of a potential bottom, influenced by positive social sentiment regarding capital discipline and potential share buybacks, alongside recent positive trial results for Amycretin, despite concerns about competition and market share.  

24-Hour: -XXX%
7-Day: -XXXX%
30-Day: -XXXX%

1-Year High: $XXXXXX on 2024-12-11  
1-Year Low: $XX on 2025-11-24  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/alt_rank.tsv)  
Novo-Nordisk (NVO) is currently AltRank #240 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX -XX  
X Month: XXX -X  
X Months: XXX +326  
X Year: XXX +6  
1-Year High: XXXXX on 2025-07-17  
1-Year Low: X on 2025-06-10  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX +18  
X Month: XX -XX  
X Months: XX -XX  
X Year: XX +17  
1-Year High: XX on 2025-06-10  
1-Year Low: XX on 2025-01-03  
  
  
### Engagements: XXXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/interactions.tsv)  
Current Value: XXXXXXX  
Daily Average: XXXXXXX  
X Week: XXXXXXXXX -XX%  
X Month: XXXXXXXXXX -XX%  
X Months: XXXXXXXXXXX +118%  
X Year: XXXXXXXXXXX +211%  
1-Year High: XXXXXXXXX on 2025-11-02  
1-Year Low: XXXXXX on 2025-01-05  

Engagements by network (24h):
Reddit: XXXXX
TikTok: XXXXX
X: XXXXXXX
YouTube: XXXXX

  
  
### Mentions: XXXXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/posts_active.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX -XXXX%  
X Months: XXXXXX +87%  
X Year: XXXXXX +128%  
1-Year High: XXXXX on 2025-11-07  
1-Year Low: XXX on 2025-03-01  

Mentions by network (24h):
Reddit: XXX
TikTok: XXX
X: XXXXX
YouTube: XXX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novo-Nordisk (NVO) in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XXX  
X Week: XXXXX -XX%  
X Month: XXXXX -XXXX%  
X Months: XXXXXX +111%  
X Year: XXXXXX +146%  
1-Year High: XXXXX on 2025-11-07  
1-Year Low: XXX on 2025-01-27  

The most influential creators that mention Novo-Nordisk in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@TheRayMyers](/creator/twitter/TheRayMyers)       | X    | XXXXXX    | XX    | XXXXXX      |
| [@DeepIceValue](/creator/twitter/DeepIceValue)     | X    | XXXXXX    | X     | XXXXXX      |
| [@investseekers](/creator/twitter/investseekers)   | X    | XXXXX     | XX    | XXXXXX      |
| [@meeijer](/creator/twitter/meeijer)               | X    | XXXXXX    | X     | XXXXX       |
| [@novonordisk](/creator/tiktok/novonordisk)        | X    | XXXXXX    | XX    | XXXXX       |
| [@TacticzH](/creator/twitter/TacticzH)             | X    | XXXXXX    | XX    | XXXXX       |
| [@Pharmdca](/creator/twitter/Pharmdca)             | X    | XXXXXXX   | X     | XXXXX       |
| [@ResearchPulse1](/creator/twitter/ResearchPulse1) | X    | XXXXX     | X     | XXXXX       |
| [@MMatters22596](/creator/twitter/MMatters22596)   | X    | XXXXXX    | XX    | XXXXX       |
| [@CNBCTV18Live](/creator/twitter/CNBCTV18Live)     | XX   | XXXXXXXXX | X     | XXXXX       |

[View More](/list/creators/$nvo/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% +4%  
X Months: XX% -X%  
X Year: XX% +5%  
1-Year High: XX% on 2025-11-02  
1-Year Low: XX% on 2025-06-23  

Most Supportive Themes:
- Positive Clinical Trial Results and Wegovy's Cardiovascular Benefits: (35%) Posts highlighting positive results from clinical trials for Novo Nordisk's drugs, particularly Wegovy, and its cardiovascular benefits.
- Long-Term Growth Potential and Valuation: (25%) Posts discussing the long-term growth potential of Novo Nordisk, especially in the obesity and diabetes markets, and its current valuation.
- Expert Analysis and Recommendations: (15%) Posts from analysts and financial experts recommending Novo Nordisk as a buy or highlighting its strengths.
  
Most Critical Themes:
- Competition and Market Share Concerns: (20%) Posts expressing concerns about increasing competition from other pharmaceutical companies, particularly Eli Lilly, and its impact on Novo Nordisk's market share.
- Negative Guidance and Restructuring: (5%) Posts discussing the company's lowered sales and operating profit outlook, job cuts, and restructuring efforts.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.27%  
X Month: XXXXX% -XXXXX%  
X Months: XXXXX% -XXXXX%  
X Year: XXXXX% -XXXX%  
1-Year High: XXXXX% on 2025-12-10  
1-Year Low: XXXX% on 2025-03-23  
  
  
### Market Dominance: XXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/market_dominance.tsv)  
Current Value: XXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-03-31  
1-Year Low: XXXX% on 2025-12-10  
  
  
### Market Cap: $XXXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXXX -$2%  
X Month: $XXXXXXXXXXXXXXX +$1.50%  
X Months: $XXXXXXXXXXXXXXX -$43%  
X Year: $XXXXXXXXXXXXXXX -$58%  
1-Year High: $XXXXXXXXXXXXXXX on 2024-12-11  
1-Year Low: $XXXXXXXXXXXXXXX on 2025-11-24  

### Top Novo-Nordisk Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"My Shocking Novo Nordisk Stock Prediction #nvo #novonordisk #stocks #trading #stockmarket #invest"  
[YouTube Link](https://youtube.com/watch?v=sWsXmJf-x3w) [@parkevtatevosiancfa9544](/creator/youtube/parkevtatevosiancfa9544) 2025-12-10T00:27Z 566K followers, XXX engagements


"I like how everyone moves with the same rules and same clarity $lqda $xpl $nvo $meta $bnb $doge $nvda $tsla $sofi #liquidity $cifr $iren #ethereum $open $aster $sol $dash $pltr $wild $mon $btc $oscr #bitcoin"  
[X Link](https://x.com/jiquilpan12344/status/1998524492453392602) [@jiquilpan12344](/creator/x/jiquilpan12344) 2025-12-09T22:45Z XX followers, XXX engagements


"@HatedMoats You think $GOOG and $ASML return more with same or lower risk than $NVO and $ADBE or $V and $PDD from here"  
[X Link](https://x.com/DeepIceValue/status/1998518681702379722) [@DeepIceValue](/creator/x/DeepIceValue) 2025-12-09T22:22Z 13K followers, XXX engagements


"Weight loss drugs fill a gap for women with hormonal disorder PCOS REUTERS"  
[YouTube Link](https://youtube.com/watch?v=NnkNwRBQOI8) [@Reuters](/creator/youtube/Reuters) 2025-12-09T20:51Z 4M followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Novo-Nordisk (NVO)

Novo Nordisk is facing legal battles over its semaglutide drug patents, with Delhi High Court hearing pleas against Sun Pharma and a pending dispute with Dr. Reddy's Laboratories. Meanwhile, analysts are debating its valuation against competitors like Eli Lilly, with some seeing undervaluation and others highlighting market share concerns.

About Novo-Nordisk

Novo Nordisk is a pharmaceutical company specializing in diabetes and obesity treatments.
Novo-Nordisk uses the ticker $NVO for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Novo-Nordisk (NVO) social dominance hit XXXXXX which is XXX% higher than it's daily average.
Novo-Nordisk (NVO) trading volume is up XXXXX% from the previous month.
Novo-Nordisk (NVO) social dominance is up XXXXXX% from the previous week.
Novo-Nordisk (NVO) Galaxy Score™ is up XXXXX% from the previous week.

Price: $XXXXX

Price 24-Hour Time-Series Raw Data
The stock price is showing signs of a potential bottom, influenced by positive social sentiment regarding capital discipline and potential share buybacks, alongside recent positive trial results for Amycretin, despite concerns about competition and market share.

24-Hour: -XXX% 7-Day: -XXXX% 30-Day: -XXXX%

1-Year High: $XXXXXX on 2024-12-11
1-Year Low: $XX on 2025-11-24

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Novo-Nordisk (NVO) is currently AltRank #240 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XX
X Month: XXX -X
X Months: XXX +326
X Year: XXX +6
1-Year High: XXXXX on 2025-07-17
1-Year Low: X on 2025-06-10

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +18
X Month: XX -XX
X Months: XX -XX
X Year: XX +17
1-Year High: XX on 2025-06-10
1-Year Low: XX on 2025-01-03

Engagements: XXXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXXXX -XX%
X Month: XXXXXXXXXX -XX%
X Months: XXXXXXXXXXX +118%
X Year: XXXXXXXXXXX +211%
1-Year High: XXXXXXXXX on 2025-11-02
1-Year Low: XXXXXX on 2025-01-05

Engagements by network (24h): Reddit: XXXXX TikTok: XXXXX X: XXXXXXX YouTube: XXXXX

Mentions: XXXXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XXXX%
X Months: XXXXXX +87%
X Year: XXXXXX +128%
1-Year High: XXXXX on 2025-11-07
1-Year Low: XXX on 2025-03-01

Mentions by network (24h): Reddit: XXX TikTok: XXX X: XXXXX YouTube: XXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Novo-Nordisk (NVO) in the last XX hours which is up XX% from XXX in the previous XX hours Daily Average: XXX
X Week: XXXXX -XX%
X Month: XXXXX -XXXX%
X Months: XXXXXX +111%
X Year: XXXXXX +146%
1-Year High: XXXXX on 2025-11-07
1-Year Low: XXX on 2025-01-27

The most influential creators that mention Novo-Nordisk in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@TheRayMyers	X	XXXXXX	XX	XXXXXX
@DeepIceValue	X	XXXXXX	X	XXXXXX
@investseekers	X	XXXXX	XX	XXXXXX
@meeijer	X	XXXXXX	X	XXXXX
@novonordisk	X	XXXXXX	XX	XXXXX
@TacticzH	X	XXXXXX	XX	XXXXX
@Pharmdca	X	XXXXXXX	X	XXXXX
@ResearchPulse1	X	XXXXX	X	XXXXX
@MMatters22596	X	XXXXXX	XX	XXXXX
@CNBCTV18Live	XX	XXXXXXXXX	X	XXXXX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% +4%
X Months: XX% -X%
X Year: XX% +5%
1-Year High: XX% on 2025-11-02
1-Year Low: XX% on 2025-06-23

Most Supportive Themes:

Positive Clinical Trial Results and Wegovy's Cardiovascular Benefits: (35%) Posts highlighting positive results from clinical trials for Novo Nordisk's drugs, particularly Wegovy, and its cardiovascular benefits.
Long-Term Growth Potential and Valuation: (25%) Posts discussing the long-term growth potential of Novo Nordisk, especially in the obesity and diabetes markets, and its current valuation.
Expert Analysis and Recommendations: (15%) Posts from analysts and financial experts recommending Novo Nordisk as a buy or highlighting its strengths.

Most Critical Themes:

Competition and Market Share Concerns: (20%) Posts expressing concerns about increasing competition from other pharmaceutical companies, particularly Eli Lilly, and its impact on Novo Nordisk's market share.
Negative Guidance and Restructuring: (5%) Posts discussing the company's lowered sales and operating profit outlook, job cuts, and restructuring efforts.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.27%
X Month: XXXXX% -XXXXX%
X Months: XXXXX% -XXXXX%
X Year: XXXXX% -XXXX%
1-Year High: XXXXX% on 2025-12-10
1-Year Low: XXXX% on 2025-03-23

Market Dominance: XXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXX% on 2025-12-10

Market Cap: $XXXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX -$2%
X Month: $XXXXXXXXXXXXXXX +$1.50%
X Months: $XXXXXXXXXXXXXXX -$43%
X Year: $XXXXXXXXXXXXXXX -$58%
1-Year High: $XXXXXXXXXXXXXXX on 2024-12-11
1-Year Low: $XXXXXXXXXXXXXXX on 2025-11-24